Related Experiment Video
Updated: Jul 22, 2026

09:39
A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
17.8K
Tag and Snag: A New Platform for Bioactive Natural Product Screening from Mixtures
Jeremy Seidel1, Yongle Du1,2, Rohin Devanathan1
1Department of Chemical and Biomolecular Engineering, University of California Berkeley, Berkeley, CA 94720-3220, USA.
Molecules (Basel, Switzerland)
|August 12, 2023
Summary
Researchers developed a new platform to identify bioactive natural products in dietary supplements. This method efficiently screens compounds for cell binding, discovering known and novel molecules for drug discovery.
Area of Science:
- Natural Product Chemistry
- Drug Discovery
- Biochemistry
Background:
- Natural products offer diverse molecules for drug screening.
- Identifying active compounds in complex mixtures is challenging and time-consuming.
Purpose of the Study:
- To develop a novel platform for probing the pharmacological potential of natural products.
- To identify bioactive compounds in dietary supplements using a cell affinity assay and computational analysis.
Main Methods:
- Shotgun derivatization of natural product extracts with isotopically labeled propanoic acid.
- Live cell affinity assay using HeLa cells to identify compounds with high cell binding.
- Computational liquid chromatography-mass spectrometry (LC-MS) analysis of derivatized compounds from cell lysate.
Main Results:
- Hundreds of compounds were derivatized, with dozens showing high affinity for HeLa cells.
- Over a thousand isotopically labeled compounds were screened, identifying known bioactive compounds and six new structures.
- Discovered three tulsinol compounds from Ocimum tenuiflorum and three novel valeraninium alkaloids from Valeriana officinalis.
Conclusions:
- The developed 'tag and snag' workflow is a viable method for natural product drug discovery.
- The newly identified valeraninium alkaloids represent a distinct class with potential for novel bioactivity.

